Team 3 "Aerosol therapy and Biotherapies for respiratory purposes" of the Centre for the Study of Respiratory Pathologies - INSERM U1100 has just obtained a European funding within the framework of the ERA-NET EuroNanoMed III call for proposals.
Team 3 "Aerosol therapy and Biotherapies for respiratory purposes" of the Centre for the Study of Respiratory Pathologies - INSERM U1100 has just obtained a European funding within the framework of the ERA-NET EuroNanoMed III call for proposals.